--- title: "Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6" type: "News" locale: "en" url: "https://longbridge.com/en/news/284570150.md" description: "Taysha Gene Therapies, a biotech company trading as TSHA on Nasdaq, will be releasing their financial results for the first quarter of 2026 on May 6, 2026. The company, specializing in AAV-based gene therapies for severe monogenic CNS diseases, will also conduct a corporate update conference call and webcast at 8:30 AM Eastern Time. This announcement was made on April 29, 2026, from Dallas." datetime: "2026-04-29T12:02:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/284570150.md) - [en](https://longbridge.com/en/news/284570150.md) - [zh-HK](https://longbridge.com/zh-HK/news/284570150.md) --- # Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 Taysha Gene Therapies, a biotech company trading as TSHA on Nasdaq, will be releasing their financial results for the first quarter of 2026 on May 6, 2026. The company, specializing in AAV-based gene therapies for severe monogenic CNS diseases, will also conduct a corporate update conference call and webcast at 8:30 AM Eastern Time. This announcement was made on April 29, 2026, from Dallas. ### Related Stocks - [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) ## Related News & Research - [REGENXBIO Advances Duchenne Gene Therapy Toward Accelerated Approval](https://longbridge.com/en/news/286443456.md) - [BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts | ONC Stock News](https://longbridge.com/en/news/287198763.md) - [MiNK Therapeutics' Q1 net loss narrows slightly](https://longbridge.com/en/news/286558132.md) - [](https://longbridge.com/en/news/286807703.md) - [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)